Скачать
The challenges of choosing between continuous BTKis and fixed-duration venetoclax for CLL
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 2026-03-10
Просмотров: 23
Описание:
Kerry Rogers, MD, The Ohio State University, Columbus, OH, discusses the challenges of choosing between continuous BTK inhibitors (BTKis) and fixed-duration venetoclax combinations for individual patients with chronic lymphocytic leukemia (CLL), considering factors such as biological features, comorbidities, and patient preferences. This interview took place at the ESH CLL 2026 congress in Stockholm, Sweden.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
